慢性过敏性肺炎；一种神秘且常致命的疾病。
Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease.
机构信息
Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK.
出版信息
Eur Respir Rev. 2020 Jul 7;29(156). doi: 10.1183/16000617.0177-2020. Print 2020 Jun 30.
Abstract
摘要
[链接]
相似文献
1
Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease.慢性过敏性肺炎；一种神秘且常致命的疾病。
Eur Respir Rev. 2020 Jul 7;29(156). doi: 10.1183/16000617.0177-2020. Print 2020 Jun 30.
2
Hypersensitivity pneumonitis.过敏性肺炎
Aust Fam Physician. 1983 Sep;12(9):646-8.
3
Hypersensitivity pneumonitis.过敏性肺炎。
Immunol Allergy Clin North Am. 2012 Nov;32(4):537-56. doi: 10.1016/j.iac.2012.08.008. Epub 2012 Sep 13.
4
Hypersensitivity pneumonitis: Principles in diagnosis and management.
Respirology. 2023 Jul;28(7):599-602. doi: 10.1111/resp.14514. Epub 2023 May 4.
5
Hypersensitivity pneumonitis.
Nat Rev Dis Primers. 2020 Aug 6;6(1):66. doi: 10.1038/s41572-020-0207-8.
6
[Chronic hypersensitivity pneumonitis complicated by recurrent pneumothorax].[慢性过敏性肺炎并发复发性气胸]
Nihon Naika Gakkai Zasshi. 2003 Feb 10;92(2):310-2. doi: 10.2169/naika.92.310.
7
[Hypersensitivity pneumonitis].[过敏性肺炎]
Nihon Rinsho. 2005 May;63 Suppl 5:156-64.
8
Hypersensitivity pneumonitis--general considerations.过敏性肺炎——一般考虑因素。
Clin Rev Allergy. 1983 Dec;1(4):451-67.
9
Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment.过敏性肺炎：发病机制的当前概念及潜在治疗靶点
Am J Respir Crit Care Med. 2019 Aug 1;200(3):301-308. doi: 10.1164/rccm.201903-0541PP.
10
The identification of hypersensitivity pneumonitis.过敏性肺炎的识别
Hosp Pract (1995). 1995 May 15;30(5):57-62, 65-6. doi: 10.1080/21548331.1995.11443199.
引用本文的文献
1
Associations of interstitial lung disease subtype and CT pattern with lung function and survival.间质性肺疾病亚型及CT表现与肺功能和生存率的相关性
Thorax. 2025 Jun 8. doi: 10.1136/thorax-2024-222149.
2
Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.RNA N6-甲基腺苷调节剂与肺纤维化的相关性：对慢性过敏性肺炎和特发性肺纤维化的影响
Front Genet. 2022 Jul 14;13:939175. doi: 10.3389/fgene.2022.939175. eCollection 2022.
3
Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis.一种源自纤维化性过敏性肺炎患者支气管肺泡灌洗的新型成纤维细胞系（SCI13D）的建立与鉴定
Biomedicines. 2021 Sep 10;9(9):1193. doi: 10.3390/biomedicines9091193.
4
Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States.美国慢性过敏性肺炎中抗原检测和避免的障碍。
Respir Res. 2021 Aug 10;22(1):225. doi: 10.1186/s12931-021-01817-6.
本文引用的文献
1
Prognostic factors in chronic hypersensitivity pneumonitis.慢性过敏性肺炎的预后因素。
Eur Respir Rev. 2020 May 15;29(156). doi: 10.1183/16000617.0167-2019. Print 2020 Jun 30.
2
Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study.支气管肺泡灌洗淋巴细胞增多症和蜂窝状改变对纤维化性过敏性肺炎患者糖皮质激素治疗效果的影响：一项回顾性队列研究
Eur Respir J. 2020 Apr 23;55(4). doi: 10.1183/13993003.01983-2019. Print 2020 Apr.
3
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.吡非尼酮治疗无法分类的进行性纤维化间质性肺疾病患者：一项双盲、随机、安慰剂对照、2 期临床试验。
Lancet Respir Med. 2020 Feb;8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29.
4
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
5
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.慢性过敏性肺炎患者中罕见的与端粒相关的蛋白改变基因变异。
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1154-1163. doi: 10.1164/rccm.201902-0360OC.
6
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?是时候改变了：特发性肺纤维化仍然是特发性的且仅纤维化吗？
Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9.
7
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.多中心评价弥漫性实质性肺疾病多学科团队会议诊断协议：病例队列研究。
Lancet Respir Med. 2016 Jul;4(7):557-565. doi: 10.1016/S2213-2600(16)30033-9. Epub 2016 May 11.
8
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.泼尼松、硫唑嘌呤和 N-乙酰半胱氨酸治疗肺纤维化。
N Engl J Med. 2012 May 24;366(21):1968-77. doi: 10.1056/NEJMoa1113354. Epub 2012 May 20.
9
Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung.皮质类固醇治疗对农民肺患者肺功能恢复的影响。
Am Rev Respir Dis. 1992 Jan;145(1):3-5. doi: 10.1164/ajrccm/145.1.3.
10
Bernardino Ramazzini (1633-1714).贝尔纳迪诺·拉马齐尼（1633 - 1714）。
Occup Health (Lond). 1979 Mar;31(3):136-41.
Zotero 插件